Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110614 · ClinicalTrials.gov registry record
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 94
- Enrollment target
NCT03110614 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 94 participants.
The verdict
NCT03110614 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
This is a prospective study to determine the relationships between pauci-inflammatory exacerbations and diastolic dysfunction, and their implications in hospitalized patients with acute exacerbations of COPD. To assess changes within subjects from stable to acute phase, a number of comparisons will be made in subjects enrolled during acute exacerbation with similar measurements made in the stable phase after recovery from exacerbation after at least 35 days from index hospitalization or prior exacerbation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2013-11-25 |
| Est. Completion | 2021-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03110614
The ClinicalTrials.gov registry entry for NCT03110614 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03110614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03110614 about?
NCT03110614 is a clinical study titled "Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD". This is a prospective study to determine the relationships between pauci-inflammatory exacerbations and diastolic dysfunction, and their implications in hospitalized patients with acute exacerbations of COPD. To assess changes within subjects from stable to acute phase, a number of comparisons will ...
What is the current status of trial NCT03110614?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2013-11-25. Estimated completion is 2021-08-30.
Who is sponsoring clinical trial NCT03110614?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.